SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 30th, 2023 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of October 24, 2023, between InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 30th, 2023 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations
COMMON SHARES OF INMED PHARMACEUTICALS INC. UNDERWRITING AGREEMENTUnderwriting Agreement • July 6th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
The undersigned, InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of InMed Pharmaceuticals Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Roth Capital Partners, LLC is acting as representative to the several Underwriters (the “Representative”) and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
PRE-FUNDED COMMON SHARES PURCHASE WARRANT INMED PHARMACEUTICALS INC.InMed Pharmaceuticals Inc. • October 30th, 2023 • Pharmaceutical preparations • New York
THIS PRE-FUNDED COMMON SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Shares. The purchase price of one share of Common Shares under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
1,780,000 COMMON SHARES AND 1,780,000 WARRANTS OF INMED PHARMACEUTICALS INC. UNDERWRITING AGREEMENTUnderwriting Agreement • November 12th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
The undersigned, InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of InMed Pharmaceuticals Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Roth Capital Partners, LLC is acting as representative to the several Underwriters (the “Representative”) and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
AT THE MARKET OFFERING AGREEMENT April 7, 2022Terms Agreement • April 7th, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
InMed Pharmaceuticals Inc., a corporation organized under the laws of British Columbia, Canada (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (the “Manager”) as follows:
INMED PHARMACEUTICALS, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATIONInMed Pharmaceuticals Inc. • December 22nd, 2021 • Pharmaceutical preparations
On October 13, 2021, the Company and BayMedica, LLC, formerly InMed LLC (“Merger Sub”), the Company’s wholly-owned subsidiary, entered into an amended and restated agreement and plan of reorganization (the “Amended Agreement”) with BayMedica, BM REP, LLC, as the stockholder representative, and certain BayMedica stockholders, pursuant to which the Company acquired all of BayMedica’s outstanding shares of common stock (the “Merger”). The Amended Agreement amended and restated the previously-reported agreement and plan of reorganization, dated as of September 10, 2021, by and among the Company, Merger Sub, BayMedica, BM REP, LLC, as the stockholder representative, and certain BayMedica stockholders, in its entirety (the “Original Agreement”).
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • February 5th, 2021 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTAgreement • June 19th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
INMED PHARMACEUTICALS INC., a company incorporated under the laws of British Columbia (the “Company”), with offices at Suite 310, 815 West Hastings St., Vancouver, British Columbia V6C 1B4 Facsimile: (604) 683-2506
PLACEMENT AGENT PREFERRED INVESTMENT OPTION INMED PHARMACEUTICALS INC.InMed Pharmaceuticals Inc. • October 30th, 2023 • Pharmaceutical preparations • New York
THIS PLACEMENT AGENT PREFERRED INVESTMENT OPTION (the “Preferred Investment Option”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on April 26, 2029 (the “Termination Date”), but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to shares (as subject to adjustment hereunder, the “Preferred Investment Option Shares”) of Common Shares. The purchase price of one share of Common Shares under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2(b). This Preferred Investment Option is being issued pursuant to that certain engagement letter, dated as of October 24, 2023, by
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 20th, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
INMED PHARMACEUTICALS INC., a company incorporated under the laws of British Columbia with offices at Suite 310, 815 West Hastings St., Vancouver, B.C., V6C 1B4 (the “Company”)
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 6th, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 1, 2022, between InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
COMMON SHARES PURCHASE WARRANT INMED PHARMACEUTICALS INC.Common Shares Purchase • November 12th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS COMMON SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on November 16, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Shares. The purchase price of one share of Common Shares under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
CONSULTING AGREEMENTConsulting Agreement • September 29th, 2023 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
InMed Pharmaceuticals Inc., a corporation registered in the Province of British Columbia and having its principal place of business at 310-815 W. Hastings St., Vancouver, BC, V6C 1B4,
Amended and Restated Agreement and Plan of ReorganizationAgreement and Plan of Reorganization • October 13th, 2021 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Amended and Restated Agreement and Plan of Reorganization (this “Agreement”), dated as of October [__], 2021, is entered into among InMed Pharmaceuticals Inc., a British Columbia, Canada corporation (“Parent”), BayMedica, LLC, a Delaware limited liability company and indirect wholly owned subsidiary of Parent (“Merger Sub”), BayMedica, Inc., a Nevada corporation (“Company”), BM REP, LLC, a Nevada limited liability company, solely in its capacity as Stockholder Representative (“Stockholder Representative”), Philip J. Barr, The Shane A. Johnson Trust DTD April 18, 1997, as amended, Shane A. Johnson TTEE, Shane A. Johnson, Charles K. Marlowe, and the other Stockholders listed on the signature pages hereto. This Agreement amends and restates in its entirety that certain Agreement and Plan of Reorganization, dated as of September 10, 2021, entered into among Parent, Merger Sub, Company, Stockholder Representative and the Stockholders listed on the signature pages thereto (the “Original
FORM OF SERIES A COMMON SHARES PURCHASE WARRANT INMED PHARMACEUTICALS INC.InMed Pharmaceuticals Inc. • September 24th, 2021 • Pharmaceutical preparations • New York
THIS SERIES A COMMON SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) ____________2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of common shares of the Company (the “Common Shares”). The purchase price of one share of Common Shares under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
THIS AGREEMENT (the “Agreement”) made as of the 28th day of October, 2015 (the “Effective Date”),Section 85 Purchase and Sale Agreement • May 27th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
INMED PHARMACEUTICALS INC., a company incorporated under the laws of British Columbia, with offices at Suite 350, 409 Granville St, Vancouver, B.C.V6C 1T2]
SHARE PURCHASE AGREEMENT AMONG MERIDEX SOFTWARE CORPORATION, BIOGEN SCIENCES INC. AND THE SHAREHOLDERS OF BIOGEN SCIENCES INC.Share Purchase Agreement • June 19th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
MERIDEX SOFTWARE CORPORATION, a corporation organized pursuant to the laws of British Columbia, and with an address at 350-409 Granville Street, Vancouver, BC V6C 1T2
COLLABORATIVE RESEARCH AGREEMENTTechnology Assignment Agreement • May 27th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
THE UNIVERSITY OF BRITISH COLUMBIA, a corporation continued under the University Act of British Columbia with offices at 103 - 6190 Agronomy Road, Vancouver, British Columbia, V6T 1Z3
TECHNOLOGY ASSIGNMENT AGREEMENTTechnology Assignment Agreement • May 27th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
THE UNIVERSITY OF BRITISH COLUMBIA, a corporation continued under the University Act of British Columbia with offices at #103-6190 Agronomy Road, Vancouver, British Columbia, V6T 1Z3
STOCK OPTION PLAN - OPTION AGREEMENTStock Option Plan - Option Agreement • March 5th, 2021 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations
This Option Agreement is entered into between INMED PHARMACEUTICALS INC. (the “Company”) and the Optionee named below pursuant to the Company Stock Option Plan (the “Plan”), a copy of which is attached hereto, and confirms that:
EMPLOYMENT AGREEMENTEmployment Agreement • December 7th, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
INMED PHARMACEUTICALS INC., a company incorporated under the laws of British Columbia with offices at Suite 310, 815 West Hastings St., Vancouver, B.C., V6C 1B4 (the “Company”)
VIA EMAIL: eadams@inmedpharma.comInMed Pharmaceuticals Inc. • July 18th, 2022 • Pharmaceutical preparations
AMENDMENT NO. 1 TO TECHNOLOGY ASSIGNMENT AGREEMENTTechnology Assignment Agreement • June 19th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
THE UNIVERSITY OF BRITISH COLUMBIA, a corporation continued under the University Act of British Columbia with offices at #103-6190 Agronomy Road, Vancouver, British Columbia, V6T 1Z3
COMMON SHARES PURCHASE WARRANT INMED PHARMACEUTICALS INC.InMed Pharmaceuticals Inc. • February 5th, 2021 • Pharmaceutical preparations • New York
THIS COMMON SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) ____________2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Shares. The purchase price of one share of Common Shares under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
InMed Pharmaceuticals Inc. Suite 310 – 815 W. Hastings Street Vancouver, British Columbia V6C 1B4InMed Pharmaceuticals Inc. • June 28th, 2024 • Pharmaceutical preparations
Reference is made to the At The Market Offering Agreement, dated as of April 7, 2022 (the “ATM Agreement”), between InMed Pharmaceuticals Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”). This letter (the “Amendment”) constitutes an agreement between the Company and Wainwright to amend the ATM Agreement as set forth herein. Defined terms that are used but not defined herein shall have the meanings ascribed to such terms in the ATM Agreement.
STOCK OPTION PLAN - OPTION AGREEMENTStock Option Plan - Option Agreement • May 27th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations
This Option Agreement is entered into between INMED PHARMACEUTICALS INC. (the "Company") and the Optionee named below pursuant to the Company Stock Option Plan (the "Plan"), a copy of which is attached hereto, and confirms that:
The Holder of Common Stock Purchase Warrants of InMed Pharmaceuticals Inc. issued February 12, 2021InMed Pharmaceuticals Inc. • March 22nd, 2022 • Pharmaceutical preparations
InMed Pharmaceuticals Inc. (the “Company”) desires to amend (i) the Securities Purchase Agreement, dated as of February 5, 2021, by and among the Company and the purchasers signatory thereto pursuant to which the Company issued, among other securities, the Warrants (as defined below) (the “Purchase Agreement”) and (ii) the Common Stock Purchase Warrant issued February 12, 2021, by the Company and the purchaser(s) signatory thereto pursuant to which the Company issued the Warrants (as defined below) (the “Warrant Agreement”).
INDEMNITY AGREEMENTIndemnity Agreement • September 24th, 2021 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
INMED PHARMACEUTICALS INC., a British Columbia company having a principal place of business at Suite 310 – 815 West Hastings St., Vancouver, British Columbia, V6C 1B4, Canada
CONSULTING AGREEMENTAgreement • December 13th, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
INMED PHARMACEUTICALS INC., a corporation registered in the Province of British Columbia and having its principal place of business at 310-815 W. Hastings St., Vancouver, BC, V6C 1B4, Canada,
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • June 19th, 2020 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
INMED PHARMACEUTICALS INC., a company incorporated under the laws of British Columbia (the “Company”), with offices at Suite 340, 200 Granville St, Vancouver, B.C.,V6C 1S4
ContractInMed Pharmaceuticals Inc. • December 13th, 2022 • Pharmaceutical preparations • New Jersey
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 9th, 2024 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations
INMED PHARMACEUTICALS INC., a company incorporated under the laws of British Columbia with offices at Suite 310, 815 West Hastings St., Vancouver, B.C., V6C 1B4 (the “Company”)
